Bausch Health Companies Inc (BHC.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 726,400 | 635,000 | 407,000 | 489,500 | 439,300 |
| Income taxes - deferred | -91,400 | -50,100 | 62,500 | 18,600 | 74,600 |
| Accounts receivable | -347,200 | -241,800 | -67,000 | -367,200 | -121,400 |
| Other Working Capital | -199,700 | -297,300 | -209,300 | -393,300 | -66,700 |
| Other Operating Activity | 648,400 | 364,700 | 297,900 | 1,068,100 | 292,900 |
| Operating Cash Flow | $736,500 | $410,500 | $491,100 | $815,700 | $618,700 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -51,100 | -46,800 | -65,800 | -80,400 | -39,600 |
| Net Acquisitions | -115,800 | -13,090,900 | -795,000 | -45,600 | -606,800 |
| Purchase Of Investment | -24,200 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 32,500 | 184,600 | 17,700 | 53,200 | 0 |
| Purchase Sale Intangibles | -100 | -9,200 | -48,800 | -73,200 | -74,300 |
| Other Investing Activity | 2,500 | 10,317,100 | -10,348,600 | -59,500 | 1,477,000 |
| Investing Cash Flow | $-156,200 | $-2,645,200 | $-11,240,500 | $-205,500 | $756,300 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | -2,300 | 100 |
| Debt Issued | 0 | 4,921,400 | 12,004,400 | 667,000 | 555,000 |
| Debt Repayment | -29,000 | -3,370,700 | -1,110,300 | -1,704,000 | -1,629,800 |
| Common Stock Issued | 0 | 0 | 1,433,700 | 0 | 0 |
| Common Stock Repurchased | 0 | -50,000 | N/A | 0 | 0 |
| Other Financing Activity | -79,500 | -175,400 | -21,500 | -43,000 | -7,400 |
| Financing Cash Flow | $-108,500 | $1,325,300 | $12,306,300 | $-1,082,300 | $-1,082,100 |
| Exchange Rate Effect | -9,800 | 3,000 | -15,100 | -14,100 | -15,300 |
| Beginning Cash Position | 958,000 | 1,864,400 | 322,600 | 808,800 | 531,200 |
| End Cash Position | 1,420,000 | 958,000 | 1,864,400 | 322,600 | 808,800 |
| Net Cash Flow | $471,800 | $-909,400 | $1,556,900 | $-472,100 | $292,900 |
| Free Cash Flow | |||||
| Operating Cash Flow | 736,500 | 410,500 | 491,100 | 815,700 | 618,700 |
| Capital Expenditure | -51,200 | -56,000 | -114,600 | -153,600 | -113,900 |
| Free Cash Flow | 685,300 | 354,500 | 376,500 | 662,100 | 504,800 |